Formulation design, optimization and in vivo evaluation of oral co-encapsulated resveratrol-humic acid colloidal polymeric nanocarriers

References

• Acharya SB, Frotan MH, Goel RK, Tripathi SK, Das PK. 1988. Pharmacological actions of Shilajit. Indian J Exp Biol. 26(10):775–787.
   PubMed Web of Science ®Google Scholar
• Agarwal SP, Anwer MDK, Khanna R, Ali A, Sultana Y. 2010. Humic acid from Shilajit-a physico-chemical and spectroscopic characterization. J Serb Chem Soc. 75(3):413–422.
   Web of Science ®Google Scholar
• Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. 2007. Shilajit: a review. Phytother Res. 21(5):401–405.
   PubMed Web of Science ®Google Scholar
• Amri A, Chaumeil JC, Sfar S, Charrueau C. 2012. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 158(2):182–193.
   PubMed Web of Science ®Google Scholar
• Anderson HA, Bick W, Hepburn A, Stewart M. 1989. Humic substances II. In: Hayes MHB, MacCarthy P, Malcolm RL, Swift RS, editors. Search of structure. Chichester (UK): Wiley-Interscience. p. 223.
   Google Scholar
• Baur AJ, Sinclair DA. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5(6):493–506.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, Mohammadi G, Hamidi A, Andalib S, Adibkia K. 2012. Comparison of physicochemical characteristics and drug release of diclofenac sodium-eudragit (R) RS100 nanoparticles and solid dispersions. Powder Technol. 219:211–216.
   Web of Science ®Google Scholar
• Buchanan CM, Buchanan NL, Edgar KJ, Little JL, Malcolm MO, Ruble KM, Wacher VJ, Wempe MF. 2007. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-beta-cyclodextrin formulations. J Pharm Sci. 96(3):644–660.
   PubMed Web of Science ®Google Scholar
• Bhagav P, Upadhyay H, Chandran S. 2011. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation. AAPS PharmSciTech. 12(4):1087–1101.
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B. 2016. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev Ind Pharm. 42(5):694–700.
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Kumar N, Patel RR, Mishra B. 2014. Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using Taguchi robust design. Adv Sci Lett. 20(5):1028–1038.
   Google Scholar
• Chaubey P, Patel RR, Mishra B. 2014. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. ExpOpin on Drug Deliv. 11(8):1163–1181.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Vuddanda PR, Mishra B, Singh S. 2010. Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles. Colloids Surf B Biointerfaces. 81(2):563–569.
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Patel RR, Chaubey P, Kumar N, Khan G, Mishra B. 2015. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin. Carbohydr Polym. 130:9–17.
   PubMed Web of Science ®Google Scholar
• Chilom G, Rice JA. 2005. Glass transition and crystallite melting in natural organic matter. Org Geochem. 36(10):1339–1346.
   Web of Science ®Google Scholar
• Chawla R, Jaiswal S, Mishra B. 2014. Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design. Expert Opin Drug Deliv. 11(1):31–43.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13(2):123–133.
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. 2009. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release. 133(1):11–17.
   PubMed Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Mooter GV, Ludwig A. 2006. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm. 314(1):72–82.
   PubMed Web of Science ®Google Scholar
• Des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. 2006. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 116(1):1–27.
   PubMed Web of Science ®Google Scholar
• Emı́lia Juan M, Buenafuente J, Casals I, Planas JM. 2002. Plasmatic levels of trans-resveratrol in rats. Food Res Int. 35(2–3):195–199.
   Web of Science ®Google Scholar
• Elshafeey AH, Kamel AO, Awad GA. 2010. Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers. Colloids Surf B Biointerfaces. 75(2):398–404.
   PubMed Web of Science ®Google Scholar
• Fremont L. 2000. Biological effects of resveratrol. Life Sci. 66(8):663–673.
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 55(1):R1–R4.
   Web of Science ®Google Scholar
• Gupta S, Dube A, Vyas SP. 2012. Development and characterization of amphotericin B loaded solid lipid nanoparticles against experimental visceral leishmaniasis. PNT. 1(1):54–67.
   Google Scholar
• Gupta S, Gupta MK. 2017. Possible role of nanocarriers in drug delivery against cervical cancer. Nano Rev Exp. 8(1):1335567.
   PubMed Web of Science ®Google Scholar
• Gupta S, Kumar P. 2012. Drug delivery using nanocarriers: Indian perspective. Proc Natl Acad Sci India Sect B Biol Sci. 82(S1):167–206.
   Google Scholar
• Gupta S, Kumar P, Gupta MK, Vyas SP. 2012. Colloidal carriers: a rising tool for therapy of tuberculosis. Crit Rev Ther Drug Carrier Syst. 29(4):299–353.
   PubMed Web of Science ®Google Scholar
• Ghosal S. 2003. Delivery system for pharmaceutical, nutritional and cosmetic ingredients. US patent no. 6558712.
   Google Scholar
• Intagliata S, Modica MN, Santagati LM, Montenegro L. 2019. Strategies to improve resveratrol systemic and topical bioavailability: An update. Antioxidants. 8(8):244.
   Web of Science ®Google Scholar
• Jiang Z, Chen K, Cheng L, Yan B, Qian W, Cao J, Li J, Wu E, Ma Q, Yang W. 2017. Resveratrol and cancer treatment: updates. Ann N Y Acad Sci. 1403(1):59–69.
   PubMed Web of Science ®Google Scholar
• Jahanshahi M, Najafpour G, Rahimnejad M. 2008. Applying the Taguchi method for optimized fabrication of bovine serum albumin (BSA) nanoparticles as drug delivery vehicles. Afr J Biotechnol. 7(4):362–367.
   Web of Science ®Google Scholar
• Kong YC, But PPH, Ng KH, Cheng KF, Cambie RC, Malla SB. 1987. Chemical studies on a Napalese panacea; Shilajit. Int J Crude Drug Res. 25(3):179–187.
   Google Scholar
• Kristl J, Teskac K, Caddeo C, Abramović Z, Sentjurc M. 2009. Improvements of cellular stress response on Resveratrol in liposomes. Eur J Pharm Biopharm. 73(2):253–259.
   PubMed Web of Science ®Google Scholar
• Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS, Kim JH, Kim YC, Sohn DH, Park H, Kwon DY. 2009. Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK . Pharmacol Res. 59(5):330–337.
   PubMed Web of Science ®Google Scholar
• Kumar N, Chaurasia S, Patel RR, Khan G, Kumar V, Mishra B. 2017. Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile. Pharm Dev Technol. 22(2):156–167.
   PubMed Web of Science ®Google Scholar
• Kurin E, Mučaji P, Nagy M. 2012. In vitro antioxidant activities of three red wine polyphenols and their mixtures: an interaction study. Molecules. 17(12):14336–14348.
   PubMed Web of Science ®Google Scholar
• Kim S, Ng WK, Dong Y, Das S, Tan RBH. 2012. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng. 108(1):37–42.
   Web of Science ®Google Scholar
• Kumar N, Chaurasia S, Patel RR, Kumar V, Mishra B. 2014. Development and optimization of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles using central composite design. Adv Sci Lett. 20(5):984–993.
   Google Scholar
• Kim J-H, Park E-Y, Ha H-K, Jo C-M, Lee W-J, Lee SS, Kim JW. 2016. Resveratrol-loaded nanoparticles induce antioxidant activity against oxidative stress. Asian-Australas J Anim Sci. 29(2):288–298.
   PubMed Web of Science ®Google Scholar
• Lu Z, Cheng B, Hu YL, Zhang YH, Zou GL. 2009. Complexation of resveratrol with cyclodextrins: solubility and antioxidant activity. Food Chem. 113(1):17–20.
   Web of Science ®Google Scholar
• Lopedota A, Trapani A, Cutrignelli A, Chiarantini L, Pantucci E, Curci R, Manuali E, Trapani G. 2009. The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. Eur J Pharm Biopharm. 72(3):509–520.
   PubMed Web of Science ®Google Scholar
• Lu X, Ji C, Xu H, Li X, Ding H, Ye M, Zhu Z, Ding D, Jiang X, Ding X, et al. 2009. Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress. Int J Pharm. 375(1-2):89–96.
   PubMedGoogle Scholar
• Mainardes RM, Evangelista RC. 2005. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 290(1-2):137–144.
   PubMedGoogle Scholar
• Mirza MA, Agarwal SP, Rahman MA, Rauf A, Ahmad N, Alam A, Iqbal Z. 2011. Role of humic acid on oral drug delivery of an antiepileptic drug. Drug Dev Ind Pharm. 37(3):310–319.
   PubMed Web of Science ®Google Scholar
• Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. 1995. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta. 235(2):207–219.
   PubMed Web of Science ®Google Scholar
• Patel RR, Khan G, Chaurasia S, Kumar N, Mishra B. 2015. Rationally developed core-shell polymeric-lipid hybrid nanoparticles as a delivery vehicle for cromolyn sodium: implications of lipid envelop on in vitro and in vivo behaviour of nanoparticles upon oral administration. RSC Adv. 5(93):76491–76506.
   Web of Science ®Google Scholar
• Pietro M, Paola C. 2004. Thermal analysis for the evaluation of the organic matter evolution during municipal solid waste aerobic composting process. Thermochim Acta. 413(1–2):209–214.
   Web of Science ®Google Scholar
• Quintanar D, Allémann E, Fessi H, Doelker E. 1998. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 24(12):1113–1128.
   PubMed Web of Science ®Google Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 26(9–10):1231–1237.
   PubMed Web of Science ®Google Scholar
• Sharma U, Badyal PN, Gupta S. 2015. Polymeric nanoparticles drug delivery to brain: a review. Int J Pharmacol Pharmaceut Sci. 2(5):60–69.
   Google Scholar
• Sharma S, Kumar P, Jaiswal A, Dube A, Gupta S. 2011. Development and characterization of doxorubicin loaded microparticles against experimental visceral leishmaniasis. J Biomed Nanotechnol. 7(1):135–136.
   PubMed Web of Science ®Google Scholar
• Signorelli P, Ghidoni R. 2005. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem. 16(8):449–466.
   PubMed Web of Science ®Google Scholar
• Shah VP, Amidon GL. 2014. GL Amidon, H. Lennernas, VP Shah, and JR Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995-backstory of BCS . Aaps J. 16(5):894–898.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS, Pandit V. 2012. Development and validation of a HPLC method for the determination of trans-resveratrol in spiked human plasma. J Adv Pharm Technol Res. 3(2):130–135.
   PubMedGoogle Scholar
• Santos KCD, Silva MF, Pereira-Filho ER, Fernandes JB, Polikarpov I, Forim MR. 2012. Polymeric nanoparticles loaded with the 3,5,3'-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics. Nanotechnol Sci Appl. 5:37–48.
   PubMedGoogle Scholar
• Singh S, Muthu MS. 2008. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation. Nanomedicine (Lond). 3(3):305–319.
   PubMed Web of Science ®Google Scholar
• Seremeta KP, Reyes Tur MI, PéRez SM, Hocht C, Taira C, HernáNdez ODL, Sosnik A. 2014. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability. Colloids Surf B Biointerface. 123:515–523.
   PubMed Web of Science ®Google Scholar
• Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S. 2015. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: in vitro, ex vivo, and in vivo investigations. Colloids Surf B Biointerface. 128:448–456.
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. 1990. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci. 94:107–141.
   Web of Science ®Google Scholar
• Vella R, Bowen C, Fenning A. 2008. Prevention of cardiovascular damage in hypertensive rats by resveratrol. Heart Lung Circ. 17S:S219–S41.
   Google Scholar
• Visser SA, Mendel H. 1971. X-ray diffraction studies on the crystallinity and molecular weight of humic acids. Soil Biol Biochem. 3(3):259–265.
   Google Scholar
• Walle T. 2011. Bioavailability of resveratrol. Ann N Y Acad Sci. 1215:9–15.
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 32(12):1377–1382.
   PubMed Web of Science ®Google Scholar
• Wan L, Sun X, Wang X, Li Y, Yu Q, Guo C. 2011. A stereospecific HPLC method and its application in determination of pharmacokinetics profile of two enantiomers of naringenin in rats. J Chromatogr Sci. 49(4):316–320.
   PubMed Web of Science ®Google Scholar
• Wong CF, Yuen KH, Peh KK. 1999. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 178(1):11–22.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Dai JD, Zhang H, Zhang X, Wang JC, Zhang Q. 2008. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol. 8(5):2422–2431.
   PubMed Web of Science ®Google Scholar
• Yadav S, Gupta S. 2015. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy. Artif Cells Nanomed Biotechnol. 43(2):93–102.
   PubMed Web of Science ®Google Scholar
• Zu Y, Zhang Y, Wang W, Zhao X, Han X, Wang K, Ge Y. 2016. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles. Drug Deliv. 23(3):981–991.
   PubMed Web of Science ®Google Scholar